Annual Report

Report overview

The report describes a challenging 2023 in which the company generated consolidated revenue of NT$203.6 billion while expanding its medical business and higher-margin activities. It highlights a 30% supply-chain carbon reduction commitment by 2030, 100% renewable energy by 2040, and net-zero emissions by 2050. The company reports 51.3% GHG reduction progress against its 2021 baseline and 26% renewable energy use in 2023.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2023
Period: 1 January 2023 – 31 December 2023
Publication date: 31 March 2024
Language
Pages
File size
Restatement: Disclosed

Standards & Assurance

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level
SBTi status
CDP score

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

ESG & Materiality

ESG data

Indicators available in this report:

Scope 1 emissions
Scope 2 emissions
Scope 3 emissions
Renewable energy
Water consumption
Waste
Employees
Women on the board
Workplace fatalities
Net zero target

Materiality

Assessment
Basis

Build your research dataset.

Original reports, structured indicators and machine-readable Markdown, tailored to your project.

Explore our services